Impact of family history of diabetes on the assessment of β-cell function

Metabolism: Clinical and Experimental

Volumn 47, Issue 5, 1998, Pages 522-528

  Alford, Frank P ^a   Henriksen, Jan Erik ^b   Rantzau, Christian ^b   Vaag, Allan ^b   Hew, Lee F ^b   Ward, Glenn M ^b   Beck Nielsen, Henning ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GLUCOSE INTOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MONOZYGOTIC TWINS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031900912     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90234-7     Document Type: Article

References (36)

1. Beck-Nielsen H, Vaag A, Damsbo P, et al: Insulin resistance in patients with NIDDM. Diabetes Care 15:418-429, 1992
2. Porte DJ: Banting Lecture: Beta cells in type II diabetes mellitus. Diabetes 40:166-180, 1990
3. Groop LC, Widen E, Ferrannini E: Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: Errors of metabolism or of methods? Diabetologia 36:1326-1331, 1993
4. DeFronzo R, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
5. Bergman RN: Lilly Lecture: Towards physiological understanding of glucose tolerance: Minimal model approach. Diabetes 38:1512-1527, 1989
6. Scheen AJ, Paquot N, Castillo MJ, et al: How to measure insulin action in vivo. Diabet Metab Rev 10:151-188, 1994
7. Rossetti L, Shulman GI, Zawalich W, et al: Effect of chronic hyperglycaemia on in vivo insulin secretion in partially pancreatectomised rats. J Clin Invest 80:1037-1044, 1987
8. Vaag A, Henriksen JE, Madsbad S, et al: Insulin secretion, insulin action and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690-698, 1995
9. Eriksson J, Franssila Kallunki A, Ekstrand A, et al: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
10. Lillioja S, Mott DM, Spraul M, et al: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329:1988-1992, 1993
11. Pimenta W, Korythowski M, Mitrakou A, et al: Pancreatic β-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 273:1855-1861, 1995
12. Johnston C, Ward WK, Beard JC, et al: Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetes. Diabet Med 7:119-125, 1990
13. Warram JH, Martin BC, Krolewski AS, et al: Slow glucose removal rate and hyperinsulinaemia precede the development of type II diabetes in the offspring of diabetes patients. Ann Intern Med 113:909-915, 1990
14. Henriksen J-E, Alford F, Handberg A, et al: Increased glucose effectiveness in normoglycaemic but insulin-resistant relatives of patients with NIDDM: A novel compensatory mechanism. J Clin Invest 94:1196-1204, 1994
15. Köbberling J, Tillil H: Empirical risk figures for first degree relatives of non-insulin-dependent diabetics, in Köbberling J, Tattersall R (eds): The Genetics of Diabetes Mellitus. London, UK, Academic, 1982, pp 201-209
16. Newman B, Selby J, King M, et al: Concordance for type 2 diabetes mellitus in male twins. Diabetologia 30:763-768, 1987
17. Chen M, Bergman RN, Pacini G, et al: Pathogenesis of age-related glucose intolerance in man: Insulin resistance and decreased β cell function. J Clin Endocrinol Metab 60:13-20, 1985
18. Kahn SE, Prigeon RL, McCulloch DK, et al: Quantification of the relationship between insulin sensitivity and beta cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
19. Lukaski HC, Johnson PE, Bolonckuk WW, et al: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810-817, 1985
20. Martin IK, Weber KM, Ward GM, et al: Application of the SAAM modelling programme to the minimal model analyses of the intravenous glucose tolerance test data. Comput Methods Programs Biomed 33:193-203, 1990
21. Hemmilä I, Dakubu S, Mukkala V-M, et al: Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 137:335-343, 1984
22. Polonsky KS, Licinio-Paixao J, Given BD, et al: Use of biosynthetic human C peptide in the measurement of insulin secretion rates in normal volunteers and type 1 diabetic patients. J Clin Invest 77:98-105, 1986
23. Van Cauter E, Mestrez F, Sturis J, et al: Estimation of insulin secretion rates from C-peptide levels: Comparison of individuals and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
24. Elahi D: In praise of the hyperglycaemic clamp. Diabetes Care 19:278-286, 1996
25. Shapiro ET, Tillil H, Rubenstein AH, et al: Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration. J Clin Endocrinol Metab 67:1094-1099, 1988
26. Bach LA, Sharpe K: Sample size for clinical and biological research. Aust NZ J Med 19:64-68, 1989
27. Ganda OP, Srikanta S, Brink SJ, et al: Differential sensitivity to β cell secretagogues in "early" type 1 diabetes mellitus. Diabetes 33:516-521, 1984
28. Byrne MM, Sturis J, Sobel RJ, et al: Elevated plasma glucose 2h post challenge predicts defects in β cell function. Am J Physiol 270:E572-E579, 1996
29. Byrne MM, Sturis J, Clement K, et al: Insulin secretory abnormalities in subjects with hyperglycaemia due to glucokinase mutations. J Clin Invest 93:1120-1130, 1994
30. Palmer JP, Einsink JW: Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients. J Clin Endocrinol Metab 41:498-503, 1975
31. Pacini G, Valerio A, Beccaro F, et al: Insulin sensitivity and beta cell responsivity are not decreased in elderly subjects with normal OGTT. J Am Geriatr Soc 36:317-323, 1988
32. Leslie RG, Volkmann HP, Poucher M, et al: Metabolic abnormalities in children of non-insulin dependent diabetics. BMJ 293:840-842, 1986
33. Haffner SM, Stern MP, Hazuda HP, et al: Increased insulin secretion concentrations in non diabetic offspring of diabetic patients. N Engl J Med 319:1297-1301, 1988
34. Haffner SM, Miettinen H, Gaskill SP, et al: Decreased insulin secretion and increased insulin resistance are independently related to the 7 year risk of NIDDM in Mexican-Americans. Diabetes 44:1386-1391, 1995
35. Vaag A, Populsen P, Kyvik K, et al: Etiology of NIDDM: Genetics versus pre- and post-natal environments? Results from twin studies. Exp Clin Endocrinol Diabetes 104:181-182, 1996 (suppl 2, abstr)
36. Hong Y, Pedersen NL, Brismar K, et al: Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81:1791-1797, 1996